Enhanced MHC Class I and Costimulatory Molecules on B16F10 Cells Byganoderma Lucidumpolysaccharides

Li-Xin Sun,Zhi-Bin Lin,Xin-Suo Duan,Jie Lu,Zhi-Hua Ge,Xue-Fei Li,Xue-Jun Li,Min Li,En-Hong Xing,You-Xin Song,Jing Jia,Wei-Dong Li
DOI: https://doi.org/10.3109/1061186x.2012.697167
2012-01-01
Journal of Drug Targeting
Abstract:Purpose: It is obvious that malignant cells evade from immune system in patients with manifest malignancy. Deficient major histocompatibility complex (MHC) class I and costimulatory molecules on malignant cells partially consist of evasion strategy since antigen bond MHC and costimulatory molecules provide two signals necessary for T cell activation. Therefore, enhancement of MHC-I and costimulatory molecules may favor restraint of the evasion. For this purpose, Ganoderma lucidum Polysaccharides (Gl-PS) was used on B16F10 melanoma cells in this study. Methods: Immunocytochemistry and flowcytometry were used to determine the H-2Kb and H-2Db (two prominent MHC class I molecules in C57BL mouse) as well as B7-1 and B7-2 (two prominent costimulatory molecules) expression on B16F10 cells after incubation with Gl-PS, while messenger ribonucleic acid (mRNA) of these molecules was detected by reverse transcription polymerase chain reaction (RT-PCR). Results: The H-2Kb and H-2Db, and B7-1 and B7-2 on B16F10 cells and mRNAs of these molecules were enhanced by Gl-PS, and more efficient antitumor cytotoxicity was induced by the Gl-PS treated cells. Conclusions: The MHC class I molecules and costimulatory molecules may be enhanced by Gl-PS, and more efficient immune cell mediated cytotoxicity against these B16F10 cells may be induced, which may favor cancer therapy.
What problem does this paper attempt to address?